These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4846414)

  • 1. Regulation of cell-mediated cytotoxicity. I. Augmentation of cell-mediated cytotoxicity induced by radiation.
    Sabbadini E
    J Exp Med; 1974 Aug; 140(2):470-80. PubMed ID: 4846414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity in graft-versus-host reaction. I. Role of donor and host spleen cells.
    Singh JN; Sabbadini E; Sehon AH
    J Exp Med; 1972 Jul; 136(1):39-48. PubMed ID: 4402394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decline of cell-mediated immunity in aging mice.
    Menon M; Jaroslow RN; Koesterer R
    J Gerontol; 1974 Sep; 29(5):499-505. PubMed ID: 4212398
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cell-mediated cytotoxicity. II. Synergism of two types of thymus dependent cells in vivo.
    Sabbadini E
    Cell Immunol; 1975 Jul; 18(1):76-87. PubMed ID: 237633
    [No Abstract]   [Full Text] [Related]  

  • 5. On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.
    Forman J
    J Exp Med; 1975 Aug; 142(2):403-18. PubMed ID: 1079848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient impaired cell-mediated tumor immunity after acute infection with lymphocytic choriomeningitis virus.
    Güttler F; Bro-Jorgensen K; Jorgensen PN
    Scand J Immunol; 1975; 4(4):327-36. PubMed ID: 1188321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes.
    Lamon EW; Shaw MW; Goodson S; Lidin B; Walia AS; Fuson EW
    J Exp Med; 1977 Feb; 145(2):302-13. PubMed ID: 833543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separable populations of activated thymus-derived lymphocytes identified in two assays for cell-mediated immunity to murine tumor allografts.
    Tigelaar RE; Gorczynski RM
    J Exp Med; 1974 Jul; 140(1):267-89. PubMed ID: 4545897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in vivo adsorption of immune serum to donor spleen cells on allograft rejection in X-irradiated mice.
    Cruse JM; Dulaney AD
    Z Immunitatsforsch Allerg Klin Immunol; 1966 May; 130(4):329-36. PubMed ID: 4231165
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of lethally irradiated mice by spleen cells from neonatally thymectomized mice.
    Yunis EJ; Good RA; Smith J; Stutman O
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2544-8. PubMed ID: 4152206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differentiation pathway of T lymphocytes. Evidence for two differentiated cell types.
    Matter A
    J Exp Med; 1974 Aug; 140(2):566-77. PubMed ID: 4152545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 20. H-2 immunogenicity of various tissue extracts as detected by growth of an allogeneic tumour.
    Hilgert I; Koubek K; Kristofová H
    Folia Biol (Praha); 1971; 17(2):73-85. PubMed ID: 4102583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.